Paper39720606
Worldwide patterns and trends in ovarian cancer incidence by histological subtype: a population-based analysis from 1988 to 2017.
Wei YF and 17 others. EClinicalMedicine, 2025. Cited by 27 papers, by iCite.
Cite this record
ConductScience Library. Worldwide patterns and trends in ovarian cancer incidence by histological subtype: a population-based analysis from 1988 to 2017. Papers, record 39720606. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39720606
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Worldwide patterns and trends in ovarian cancer incidence by histological subtype: a population-based analysis from 1988 to 2017.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References55
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27054934 | Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk. | Obstet Gynecol | 2016 | https://conductscience.org/library/papers/27054934 | PubMed |
| 2 | 37672283 | Salpingectomy for the Primary Prevention of Ovarian Cancer: A Systematic Review. | JAMA Surg | 2023 | https://conductscience.org/library/papers/37672283 | PubMed |
| 3 | 27522007 | A global view on cancer incidence and national levels of the human development index. | Int J Cancer | 2016 | https://conductscience.org/library/papers/27522007 | PubMed |
| 4 | 27325851 | Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium. | J Clin Oncol | 2016 | https://conductscience.org/library/papers/27325851 | PubMed |
| 5 | 1520204 | Endometriosis and race. | Aust N Z J Obstet Gynaecol | 1992 | https://conductscience.org/library/papers/1520204 | PubMed |
| 6 | 37636422 | Knowledge toward ovarian cancer symptoms among women in Syria: Cross-sectional study. | Heliyon | 2023 | https://conductscience.org/library/papers/37636422 | PubMed |
| 7 | 38572751 | Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. | CA Cancer J Clin | 2024 | https://conductscience.org/library/papers/38572751 | PubMed |
| 8 | 8816606 | Ovulation induction, infertility, and ovarian cancer risk. | Fertil Steril | 1996 | https://conductscience.org/library/papers/8816606 | PubMed |
| 9 | 7640237 | Recent trends in incidence of and mortality from breast, ovarian and endometrial cancers in England and Wales and their relation to changing fertility and oral contraceptive use. | Br J Cancer | 1995 | https://conductscience.org/library/papers/7640237 | PubMed |
| 10 | 26091520 | Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk. | PLoS One | 2015 | https://conductscience.org/library/papers/26091520 | PubMed |
| 11 | 36968229 | Trends of Ovarian Cancer Incidence by Histotype and Race/Ethnicity in the United States 1992-2019. | Cancer Res Commun | 2023 | https://conductscience.org/library/papers/36968229 | PubMed |
| 12 | 25935772 | National trends of adnexal surgeries at the time of hysterectomy for benign indication, United States, 1998-2011. | Am J Obstet Gynecol | 2015 | https://conductscience.org/library/papers/25935772 | PubMed |
| 13 | 24689070 | Genetics and genomic medicine in Israel. | Mol Genet Genomic Med | 2014 | https://conductscience.org/library/papers/24689070 | PubMed |
| 14 | 33809880 | How Does Endometriosis Lead to Ovarian Cancer? The Molecular Mechanism of Endometriosis-Associated Ovarian Cancer Development. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33809880 | PubMed |
| 15 | 11936824 | Practical implications of imposing a new world standard population. | Cancer Causes Control | 2002 | https://conductscience.org/library/papers/11936824 | PubMed |
| 16 | 14662224 | Alcohol consumption and the risk of mucinous and nonmucinous epithelial ovarian cancer. | Obstet Gynecol | 2003 | https://conductscience.org/library/papers/14662224 | PubMed |
| 17 | 31377935 | Assisted reproductive technology and risk of ovarian cancer and borderline tumors in parous women: a population-based cohort study. | Eur J Epidemiol | 2019 | https://conductscience.org/library/papers/31377935 | PubMed |
| 18 | 21683865 | Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm. | Hum Pathol | 2011 | https://conductscience.org/library/papers/21683865 | PubMed |
| 19 | 37348095 | Health Disparities in Ovarian Cancer: Report From the Ovarian Cancer Evidence Review Conference. | Obstet Gynecol | 2023 | https://conductscience.org/library/papers/37348095 | PubMed |
| 20 | 27558151 | Ovarian cancer. | Nat Rev Dis Primers | 2016 | https://conductscience.org/library/papers/27558151 | PubMed |
Cited by24
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42894150 | Ovarian cancer in Asia: incidence, mortality in 2022, and future projections to 2050. | BMC Public Health | 2026 | https://conductscience.org/library/papers/42894150 | PubMed |
| 42696959 | A chemoresistance-associated proliferation gene signature identified by single-cell and machine learning analysis predicts prognosis in high-grade serous ovarian carcinoma. | Transl Oncol | 2026 | https://conductscience.org/library/papers/42696959 | PubMed |
| 42649936 | Overcoming Therapy Resistance in Ovarian Cancer: From Molecular Mechanisms to Emerging Therapeutic Strategies. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42649936 | PubMed |
| 42458283 | Comparing and combining O-RADS ultrasound, serum CA125, and HE4 for the preoperative diagnosis of ovarian tumors. | BMC Med Imaging | 2026 | https://conductscience.org/library/papers/42458283 | PubMed |
| 42351676 | Synergistic Effects of Doxorubicin and Quercetin on ROS-Associated Apoptosis and EGFR/FOXP3 Modulation in OVCAR3 Cells. | Biomedicines | 2026 | https://conductscience.org/library/papers/42351676 | PubMed |
| 42284540 | Clinicogenomic Landscape of Histologic Subtypes in Ovarian Cancer: Real-World Evidence From a Japanese Nationwide Cohort. | JCO Precis Oncol | 2026 | https://conductscience.org/library/papers/42284540 | PubMed |
| 42192949 | Talc Exposure and Risk of Ovarian Cancer: A Systematic Review and Meta-Analysis with Limited Evidence on Cervical and Endometrial Cancers. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42192949 | PubMed |
| 42087098 | Physical activity, sedentary behavior and ovarian cancer risk in Asian populations: a scoping review and meta-analysis. | BMC Cancer | 2026 | https://conductscience.org/library/papers/42087098 | PubMed |
| 41969520 | Identification and validation of a sphingolipid metabolism-related prognostic signature for predicting prognosis and immune microenvironment-related characteristics in ovarian cancer. | Transl Cancer Res | 2026 | https://conductscience.org/library/papers/41969520 | PubMed |
| 41955969 | Superiority of the ROMA index over HE4 and CA125 for diagnosing ovarian cancer in a Bangladeshi cohort. | Clinics (Sao Paulo) | 2026 | https://conductscience.org/library/papers/41955969 | PubMed |
| 41867005 | Cancer mortality predictions for 2026 in selected Asian countries and Australia with focus on prostate cancer. | Eur J Cancer Prev | 2026 | https://conductscience.org/library/papers/41867005 | PubMed |
| 41799512 | Clinical and Functional Characterization of PDE1A as a Wnt/β-Catenin-Linked Biomarker of Progression and Platinum Resistance in Epithelial Ovarian Cancer. | Oncol Res | 2026 | https://conductscience.org/library/papers/41799512 | PubMed |
| 41786760 | Ovarian cancer. | Nat Rev Dis Primers | 2026 | https://conductscience.org/library/papers/41786760 | PubMed |
| 41776662 | Deep spatial transcriptomic profiling of ovarian clear cell carcinoma in the real-world setting. | J Ovarian Res | 2026 | https://conductscience.org/library/papers/41776662 | PubMed |
| 41728398 | Epidemiological Profile, Clinical Characteristics, and Management of Ovarian Cancer in Eastern India: A Hospital-Based Study. | Cureus | 2026 | https://conductscience.org/library/papers/41728398 | PubMed |
| 41636865 | The impact of genetic variants of the IGF-1 axis on surgical outcomes and prognosis in ovarian cancer. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/41636865 | PubMed |
| 41596365 | Integrated Analyses Identify CDH2 as a Hub Gene Associated with Cisplatin Resistance and Prognosis in Ovarian Cancer. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41596365 | PubMed |
| 41454273 | Incidence of different histologic subtype of ovarian cancer in China: a population-based cancer registry study. | BMC Womens Health | 2025 | https://conductscience.org/library/papers/41454273 | PubMed |
| 41286938 | The role of ITGA3 expression in predicting liver metastasis in patients with epithelial ovarian cancer. | BMC Med Genomics | 2025 | https://conductscience.org/library/papers/41286938 | PubMed |
| 41029118 | Association between the oxidative balance score and gynecologic cancers from the National Health and Nutrition Examination Survey: An observational study. | Medicine (Baltimore) | 2025 | https://conductscience.org/library/papers/41029118 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39720606
GET https://conductscience.org/api/papers/v1/39720606/references?page=2